GLP-1 'comeback' videos: what the science says about restart claims

What did @bellamiuw actually say?

The creator posted a "shot day" video promoting Revive Med Philly, claiming to have lost "about 20 pounds" in "about two months" on a GLP-1 medication. She says she was prescribed 15 units but self-adjusted down to 10, calls the injection painless, and reports "no side effects." She credits the medication alongside working out and eating healthy, and closes with a direct call to action to book an appointment.

A few things stand out immediately. She mentions "units" as her dosing language, which is unusual for semaglutide or tirzepatide (typically measured in milligrams). She does not name the specific drug, and she describes modifying her prescribed dose without any clinical guidance offered. The video functions as a paid or affiliate promotion for a specific telehealth clinic.

Does the science back this up?

The 20-pound-in-two-months claim is plausible but sits at the high end of what clinical trials show, especially early in treatment. It is not impossible, but it deserves context.

In the STEP 1 trial (Wilding et al., 2021, NEJM), participants on semaglutide 2.4mg lost an average of 14.9% body weight over 68 weeks, not two months. Early weight loss is often more rapid due to appetite suppression and reduced caloric intake, so a heavier starting weight could produce 20 lbs in two months. However, averaging that across a population, it represents an outlier result, not a typical expectation. Tirzepatide data from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed even stronger weight loss, with some participants losing significantly more, so the specific drug matters here. Without knowing her starting weight or which compound she is actually taking, the 20-pound figure cannot be fully evaluated, but it should not be presented as a standard outcome new patients should expect.

What did they get wrong (or right)?

Credit where it is due: she explicitly says she is "working out, eating healthy, staying on track" alongside the medication. That is accurate and important. GLP-1 receptor agonists work best as part of a comprehensive lifestyle intervention, not as a standalone fix. Most clinical trials require lifestyle modification alongside pharmacotherapy, and she models that correctly.

What she got wrong is more concerning. Saying "no side effects" for GLP-1 therapy is almost statistically improbable. In STEP 1, over 70% of semaglutide participants reported gastrointestinal side effects including nausea, vomiting, and diarrhea. Saying she has none does not mean others will have none, and framing zero side effects as the expected experience is misleading to a general audience. More concerning is mentioning she takes 10 units instead of her prescribed 15. Self-adjusting doses downward without explaining why sets a poor precedent. Dose titration on GLP-1 medications is clinically managed for a reason: going too low can reduce efficacy, while going too fast can worsen side effects.

What should you actually know?

GLP-1 receptor agonists are legitimate, FDA-approved medications with strong clinical evidence behind them. But the way this video presents the experience strips out almost all the clinical nuance a real patient needs.

First, side effects are common. Nausea affects the majority of users, particularly during dose escalation. The fact that this creator says she has none is not a lie, but it is an outlier experience that should not anchor anyone's expectations. Second, self-adjusting your dose without talking to your prescriber is not a best practice. Dose titration protocols exist because the pharmacology of these drugs requires gradual escalation. Third, results vary significantly by starting weight, metabolic health, diet quality, and exercise habits. Twenty pounds in two months is not a promise. Finally, compounded GLP-1 medications from telehealth platforms are not the same as FDA-approved brand-name drugs. Compounded semaglutide, for example, has faced FDA scrutiny regarding purity and dosing accuracy. Patients deserve to know that distinction before booking.

The bottom line

This video is enthusiastic promotion for a telehealth clinic, not a balanced patient experience. The creator gets credit for emphasizing lifestyle changes alongside the medication. But the "no side effects" framing is statistically misleading, the dose self-adjustment is not clinically endorsed behavior, and the 20-pound result is real but not representative. If you are considering a GLP-1 medication, talk to a licensed clinician, ask specifically about gastrointestinal side effects and the titration schedule, and do not expect your results to match a TikTok testimonial.